| Dr Troy J Markus, DO | |
|
1415 E. Kincaid Street, Mount Vernon, WA 98274-4126 | |
| (360) 424-4111 | |
| Not Available |
| Full Name | Dr Troy J Markus |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 1415 E. Kincaid Street, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588862007 | NPI | - | NPPES |
| OP60067007 | Other | WA | WA MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | OP60067007 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Emergency Physicians Llc | 3476462334 | 186 |
News Archive
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.
We appreciate the hard work and long hours the subcommittee has invested in scientific peer review of the FDA's draft safety assessment of the use of BPA in food contact applications.
Illumina, Inc. today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.
› Verified 2 days ago
| Entity Name | Northwest Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172370 PECOS PAC ID: 3476462334 Enrollment ID: O20041214000892 |
News Archive
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.
We appreciate the hard work and long hours the subcommittee has invested in scientific peer review of the FDA's draft safety assessment of the use of BPA in food contact applications.
Illumina, Inc. today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Troy J Markus, DO 1415 E. Kincaid Street, Mount Vernon, WA 98274-4126 Ph: (360) 424-4111 | Dr Troy J Markus, DO 1415 E. Kincaid Street, Mount Vernon, WA 98274-4126 Ph: (360) 424-4111 |
News Archive
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
A new study reveals how the production of a potent immune regulator called interferon gamma (IFNg) is controlled in natural killer (NK) cells, immune cells that typically defend the body against cancer and infections.
We appreciate the hard work and long hours the subcommittee has invested in scientific peer review of the FDA's draft safety assessment of the use of BPA in food contact applications.
Illumina, Inc. today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.
› Verified 2 days ago
Sarah Mcdaniel, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Hospital Pkwy, Mount Vernon, WA 98273 Phone: 360-428-2166 | |
Dr. Michael Matthews Chmel, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Dr. Michael K Olpin, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Anne L Saarheim-riggs, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-428-2500 Fax: 360-428-6485 | |
Dr. Kevin Roy Bowman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Dr. Marsha Janette Tomlinson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1415 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Dr. Tara L. Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-428-6434 Fax: 360-848-4233 |